Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors

Gisbert Schneider1, Tim Geppert, Markus Hartenfeller

  • 1Swiss Federal Institute of Technology, Department of Chemistry & Applied Biosciences, 8093 Zürich, Switzerland. gisbert.schneider@pharma.ethz.ch

Abstract